MY182607A - Combination composition, comprising as active ingredients l-carnitine or propionyl l-carnitine, for the prevention or treatment of chronic venous insufficiency - Google Patents
Combination composition, comprising as active ingredients l-carnitine or propionyl l-carnitine, for the prevention or treatment of chronic venous insufficiencyInfo
- Publication number
- MY182607A MY182607A MYPI2012002962A MYPI2012002962A MY182607A MY 182607 A MY182607 A MY 182607A MY PI2012002962 A MYPI2012002962 A MY PI2012002962A MY PI2012002962 A MYPI2012002962 A MY PI2012002962A MY 182607 A MY182607 A MY 182607A
- Authority
- MY
- Malaysia
- Prior art keywords
- carnitine
- propionyl
- prevention
- treatment
- active ingredients
- Prior art date
Links
- PHIQHXFUZVPYII-ZCFIWIBFSA-N (R)-carnitine Chemical compound C[N+](C)(C)C[C@H](O)CC([O-])=O PHIQHXFUZVPYII-ZCFIWIBFSA-N 0.000 title abstract 2
- UFAHZIUFPNSHSL-MRVPVSSYSA-N O-propanoyl-L-carnitine Chemical compound CCC(=O)O[C@H](CC([O-])=O)C[N+](C)(C)C UFAHZIUFPNSHSL-MRVPVSSYSA-N 0.000 title abstract 2
- 239000004480 active ingredient Substances 0.000 title abstract 2
- 230000002265 prevention Effects 0.000 title abstract 2
- 201000002816 chronic venous insufficiency Diseases 0.000 title 1
- 229960001518 levocarnitine Drugs 0.000 title 1
- 201000002282 venous insufficiency Diseases 0.000 title 1
- QUQPHWDTPGMPEX-UHFFFAOYSA-N Hesperidine Natural products C1=C(O)C(OC)=CC=C1C1OC2=CC(OC3C(C(O)C(O)C(COC4C(C(O)C(O)C(C)O4)O)O3)O)=CC(O)=C2C(=O)C1 QUQPHWDTPGMPEX-UHFFFAOYSA-N 0.000 abstract 1
- 208000037998 chronic venous disease Diseases 0.000 abstract 1
- GZSOSUNBTXMUFQ-YFAPSIMESA-N diosmin Chemical compound C1=C(O)C(OC)=CC=C1C(OC1=C2)=CC(=O)C1=C(O)C=C2O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO[C@H]2[C@@H]([C@H](O)[C@@H](O)[C@H](C)O2)O)O1 GZSOSUNBTXMUFQ-YFAPSIMESA-N 0.000 abstract 1
- 229960004352 diosmin Drugs 0.000 abstract 1
- QUQPHWDTPGMPEX-QJBIFVCTSA-N hesperidin Chemical compound C1=C(O)C(OC)=CC=C1[C@H]1OC2=CC(O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@@H](CO[C@H]4[C@@H]([C@H](O)[C@@H](O)[C@H](C)O4)O)O3)O)=CC(O)=C2C(=O)C1 QUQPHWDTPGMPEX-QJBIFVCTSA-N 0.000 abstract 1
- IKGXIBQEEMLURG-NVPNHPEKSA-N rutin Chemical compound O[C@@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@H]1OC[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@H](OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 IKGXIBQEEMLURG-NVPNHPEKSA-N 0.000 abstract 1
- 229960003232 troxerutin Drugs 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/205—Amine addition salts of organic acids; Inner quaternary ammonium salts, e.g. betaine, carnitine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
- A61K31/221—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin with compounds having an amino group, e.g. acetylcholine, acetylcarnitine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Molecular Biology (AREA)
- Emergency Medicine (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
It is described a combination composition comprising as active ingredients L--carnitine or propionyl L-carnitine, troxerutine, diosmine and hesperidine, useful for the prevention and/or treatment of chronic venous diseases.
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP10152363A EP2353596A1 (en) | 2010-02-02 | 2010-02-02 | Combination composition, comprising as active ingredients L-carnitine or propionyl L-carnitine, for the prevention or treatment of chronic venous insufficiency |
| US32253210P | 2010-04-09 | 2010-04-09 | |
| PCT/IB2011/000200 WO2011095882A1 (en) | 2010-02-02 | 2011-02-07 | Combination composition, comprising as active ingredient l-carnitine or propionyl l-carnitine, for the prevention or treatment of chronic venous insufficiency |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MY182607A true MY182607A (en) | 2021-01-26 |
Family
ID=51844410
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MYPI2012002962A MY182607A (en) | 2010-02-02 | 2011-02-07 | Combination composition, comprising as active ingredients l-carnitine or propionyl l-carnitine, for the prevention or treatment of chronic venous insufficiency |
Country Status (7)
| Country | Link |
|---|---|
| CA (1) | CA2787470C (en) |
| CL (1) | CL2012001740A1 (en) |
| HR (1) | HRP20140785T1 (en) |
| MY (1) | MY182607A (en) |
| PH (1) | PH12012501249A1 (en) |
| SM (1) | SMT201400121B (en) |
| ZA (1) | ZA201206518B (en) |
-
2011
- 2011-02-07 PH PH1/2012/501249A patent/PH12012501249A1/en unknown
- 2011-02-07 MY MYPI2012002962A patent/MY182607A/en unknown
- 2011-02-07 HR HRP20140785AT patent/HRP20140785T1/en unknown
- 2011-02-07 CA CA2787470A patent/CA2787470C/en not_active Expired - Fee Related
-
2012
- 2012-06-25 CL CL2012001740A patent/CL2012001740A1/en unknown
- 2012-08-30 ZA ZA2012/06518A patent/ZA201206518B/en unknown
-
2014
- 2014-09-01 SM SM201400121T patent/SMT201400121B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CA2787470A1 (en) | 2011-08-11 |
| CA2787470C (en) | 2018-03-27 |
| HRP20140785T1 (en) | 2014-11-07 |
| CL2012001740A1 (en) | 2012-11-09 |
| SMT201400121B (en) | 2014-11-10 |
| PH12012501249A1 (en) | 2017-04-07 |
| ZA201206518B (en) | 2013-05-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX2012008890A (en) | Combination composition, comprising as active ingredient l-carnitine or propionyl l-carnitine, for the prevention or treatment of chronic venous insufficiency. | |
| WO2012083048A3 (en) | Anti-viral compounds | |
| WO2012083053A3 (en) | Anti-viral compounds | |
| MY164356A (en) | Substituted 5-fluoro-1h-pyrazolopyridines and their use | |
| NZ628294A (en) | Compositions and methods of use of phorbol esters for the treatment of stroke | |
| WO2012083061A3 (en) | Anti-viral compounds | |
| WO2012125544A3 (en) | Necroptosis inhibitors and methods of use therefor | |
| IN2012DN00624A (en) | ||
| WO2012083058A3 (en) | Anti-viral compounds | |
| WO2011076367A3 (en) | Synergistic antiviral composition and use thereof | |
| WO2011042902A3 (en) | Microcapsules comprising benzoyl peroxide and topical compositions comprising them | |
| MX359181B (en) | Collagen hydrolysate and use thereof. | |
| WO2012162580A3 (en) | Anti-viral compounds | |
| WO2012162578A3 (en) | Anti-viral compounds | |
| WO2012024399A3 (en) | Compositions comprising paulownin and/or paulownia extracts and uses thereof | |
| MX2013002261A (en) | Substituted n-phenethyltriazoloneacetamides and use thereof. | |
| WO2012065028A3 (en) | Substituted tetracyclines | |
| WO2011156820A9 (en) | Compositions, methods and uses for treatment of type 1 diabetes | |
| HK1203379A1 (en) | β-ARRESTIN EFFECTORS AND COMPOSITIONS AND METHODS OF USE THEREOF | |
| MY182607A (en) | Combination composition, comprising as active ingredients l-carnitine or propionyl l-carnitine, for the prevention or treatment of chronic venous insufficiency | |
| WO2014004178A3 (en) | Compositions comprising substituted phenols and topical application thereof | |
| NZ613887A (en) | Antimicrobial activity enhancing agent | |
| IN2014KN02584A (en) | ||
| WO2011073439A3 (en) | Use of peptides as antidandruff agents | |
| WO2010142981A3 (en) | Composition and uses thereof |